Clinical Trial: A randomized controlled trial on the effect of semaglutide on cardiovascular outcomes in patients with chronic heart failure with preserved ejection fraction and type 2 diabetes mellitus (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized controlled trial on the effect of semaglutide on cardiovascular outcomes in patients with chronic heart failure with preserved ejection fraction and type 2 diabetes mellitus'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130443

Registration Time: 2026/08/20

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336747

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A randomized controlled trial on the effect of semaglutide on cardiovascular outcomes in patients with chronic heart failure with preserved ejection fraction and type 2 diabetes mellitus (China)